Eaton Vance Management Meridian Bioscience Inc Transaction History

Eaton Vance Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$23.75 - $31.69 $440,325 - $587,532	-18,540 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$19.97 - $26.94 $1,917 - $2,586	96 Added 0.52%	18,540 $482,000
Q4 2021 Feb 14, 2022	BUY	$17.46 - $21.61 $2,915 - $3,608	167 Added 0.91%	18,444 $0
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $55,173 - $71,550	-3,180 Reduced 14.82%	18,277 $0
Q2 2021 Aug 16, 2021	BUY	$18.01 - $28.32 $383,162 - $602,508	21,275 Added 11689.56%	21,457 $476,000
Q1 2021 May 17, 2021	BUY	$19.76 - $29.89 $3,596 - $5,439	182 New	182 $5,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.